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Summary 
The K+ channel interacting proteins (KChIPs) are EF hand-containing proteins 
required for the traffic of channel-forming Kv4 K+ subunits to the plasma membrane. 
KChIP1 is targeted, through N-terminal myristoylation, to intracellular vesicles that 
appear to be intermediates in traffic from the ER to the Golgi but differ from those 
underlying conventional ER-Golgi traffic. To define KChIP1vesicles and the traffic 
pathway followed by Kv4/KChIP1 traffic, we examined their relationship to potential 
SNARE proteins mediating the traffic step. To distinguish Kv4/KChIP1 from 
conventional constitutive traffic we compared it to the traffic of the vesicular 
stomatitis G-protein (VSVG). Expression of KChIP with single or triple EF hand 
mutation quantitatively inhibited Kv4/KChIP1 traffic to the cell surface but had no 
effect on VSVG traffic.  KChIP1-expressing vesicles co-localised with the SNARE 
proteins Vti1a and VAMP7 but not with the components of two other ER-Golgi 
SNARE complexes.  siRNA-mediated knock down of Vti1a or VAMP7 inhibited 
Kv4/KChIP1traffic to the plasma membrane in HeLa and Neuro2A cells. Vti1a and 
VAMP7 siRNA had no effect on VSVG traffic or that of Kv4.2 when stimulated by 
KChIP2, a KChIP with different intrinsic membrane targeting compared to KChIP1. 
These data suggest that a SNARE complex containing VAMP7 and Vti1a defines a 
novel traffic pathway to the cell surface in both neuronal and non-neuronal cells. 
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Introduction 
Kv4 potassium channels were first identified as homologues of the Drosophila Shal 
channels and are now known to have key roles in the regulation of the excitability of 
neurons and cardiac myocytes.  In mammals, four members of the Kv4 family (Kv4.1, 
4.2, 4.3 short and 4.3 long) are known [1] and they are highly expressed in the brain 
and heart [2]. Kv4 potassium channels are responsible for the transient, outward, A-
type current in neurons, and its equivalent in myocytes. In the brain, it is thought that 
this current is responsible for attenuating back propagating action potentials and 
excitatory post-synaptic potentials [3]. The channels also limit action potentials to 
individual dendritic compartments  [4] and abnormalities in Kv4 channel function 
have been implicated in the hyperexcitability underlying epilepsy [5]. 
When Kv4 channels are expressed alone in non-neuronal cells their properties differ 
from those seen with native channels [6]. A search for interacting partners that could 
reconstitute native functions led to the discovery of the K+ channel interacting proteins 
(KChIPs) [6] which are members of the neuronal calcium sensor (NCS) family of 
proteins [7, 8]. The KChIPs have four EF-hand domains of which 3 can potentially  
bind Ca2+ and 2 were seen to be occupied by Ca2+ in the crystal structure of KChIP1 
[9, 10]. Of the four KChIPs, only KChIP1 has an N-terminal myristoyl group required 
for it to bind to membranes [11] and uniquely allowing its targeting to a distinct 
population of intracellular 50-100 nm diameter vesicles (referred from now onwards 
as KChIP1 vesicles) that partially overlap with markers of the ER-Golgi intermediate 
compartment (ERGIC) [12]. The KChIPs have two effects on Kv4 channels. Firstly, 
the KChIPs modulate the properties of the channel, particularly its inactivation 
kinetics [6]. Secondly, they increase current density by promoting the traffic of the 
Kv4 channel to the plasma membrane [6, 12-15]. Kv4 proteins alone are able to exit 
from the ER, but then become trapped in the Golgi complex [11, 12]. Co-expression 
of Kv4 channels with KChIPs leads to their traffic and co-localization at the plasma 
membrane[11, 12] where the KChIPs are constitutive channel subunits [9, 10].  
The conventional exocytic pathway from the ER has been studied in detail by 
following the traffic of a temperature sensitive mutant of the vesicular stomatitis virus 
(VSV) G protein [16, 17]. Traffic of VSVG from the ER involves budding of COPII-
coated vesicles controlled by the GTPase Sar1 [18] and requires Rab1 [19]. The 
vesicle then passes through the intermediate compartment, the ERGIC [20] and 
through the Golgi complex in a COPI-dependent manner before traffic to the plasma 
membrane. There is growing evidence in the literature that this single pathway is not 
responsible for all traffic from the ER to the Golgi. In yeast, there is evidence that 
both COPII and COPI coated vesicles can bud from the ER [21]. Proteins bound to the 
membrane via a GPI anchor are found in vesicles distinct from those carrying standard 
marker proteins [22, 23]. In mammalian cells, procollagen is too large to fit into the 
60-80nm diameter COPII vesicles. Whilst procollagen appears to require COPII for 
exit from the ER, it is not found in COPII-coated vesicles, and has no requirement for 
COPI [24, 25]. Also, several proteins known to affect the transport of the marker 
VSVG do not affect procollagen transport and vice versa [25]. In the intestine, distinct 
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triacylglycerol transport vesicles, (pre-chylomicron transport vesicles (PCTVs)) can 
bud from the ER in a COPII-independent manner, and are lacking in COPI, but need 
COPII later in the pathway, to fuse with the Golgi [26].  Rab1-independent traffic 
from the ER has been suggested to occur for some cargos in non-neuronal [27] and 
neuronal cell types [28]. It has been shown that the traffic of Kv4 channels, with 
associated KChIP1, also occurs by an alternate pathway that is COPII-independent 
[12].  KChIP1 vesicles seem to be key intermediates in ER to Golgi traffic but the 
nature of this pathway and the KChIP1 vesicles involved in traffic are unknown.  
Membrane traffic steps can be defined by the nature of the SNARE complex that 
underlies the fusion of vesicles with their target membrane. SNAREs have been 
defined as Q or R SNAREs and based on sequence classification of SNARE 
subfamilies, active complexes appear to have the composition QaQbQcR [29]. Three 
such complexes have been implicated in ER to Golgi traffic. From analysis of VSVG 
traffic, the SNARE complex for the step between ER and the ERGIC consists of 
Sec22b, membrin, rBet1 and syntaxin 5 [30, 31]. The complex of GOS28, Ykt6, rBet1 
and syntaxin 5 is thought to be involved in the fusion of intermediates with the cis-
Golgi  [32]. Finally, a third complex, comprising VAMP7, Vti1a, rBet1 and syntaxin 
5, has been identified in the alternative ER to Golgi trafficking pathway for PCTVs in 
intestinal cells [4, 33]. The general significance of this latter complex in cargo traffic 
is unknown. We aimed to further characterise the nature of the KChIP1 vesicles and 
the traffic route taken by Kv4/KChIP1. The results show that the KChIP1 vesicles and 
Kv4/KChIP1 traffic are distinguished by a VAMP7/Vti1a containing SNARE 
complex. 
 
 
Methods 
Cell culture and transfection 
HeLa cells were grown in Dulbecco’s modified Eagle’s medium (Gibco, UK), with 
5% foetal bovine serum (Gibco, UK), 1% non-essential amino acids (Gibco, UK), and 
1% penicillin-streptomycin (10,000 units/ml penicillin, 10,000µg/ml streptomycin, 
Gibco, UK) and kept at 37°C, in a 5% CO2 atmosphere. Neuro2A cells were cultured 
in DMEM , with 10% FBS and 1% Penicillin/Streptomycin. For transfection, cells 
were grown in 24-well plates, with glass coverslips for imaging studies. Cells were 
plated at ~4 x 105 cells per well, in 1ml supplemented media, and incubated 5-24 
hours before transfection. For the transfection reaction mixture, 3µl per µg DNA of 
GeneJuice (Novagen, USA) was incubated for 5 minutes at room temperature with 
OptiMEM serum-free media (Gibco, UK) to give a total reaction volume of 100µl. 
One microgram of each plasmid DNA was then added and the mixture incubated for a 
further 15 minutes, before being added drop-wise to the cells. Cells were then left for 
24-72 hours post-transfection.  
Plasmids 
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Plasmids encoding KChIP1, KChIP1-EYFP, KChIP1EF2-4-EYFP, KChIP1EF2-4-
dsRed, KChIP2-ECFP ARF1-EYFP and Kv4.2 were described previously [11, 12, 34, 
35]. The KChIP1EF3-EYFP plasmid bearing the mutations D135A, G140A was 
prepared in this laboratory by Dr Burcu Hasdemir. The  ts045 VSVG-GFP plasmid 
[17] was provided by  John Presley (NIH, Bethesda, Maryland, USA). The plasmid 
encoding the Rab1 GAP TBC1D20 was a gift from Francis Barr (School of Cancer 
Studies, University of Liverpool). The EYFP-Golgi plasmid encoding EYFP linked to 
the N-terminus of beta 1,4-galactosyltransferase for trans- and medial-Golgi targeting 
was obtained from Clontech (California, USA). 
Immunocytochemistry 
After transfection, cells on coverslips were gently washed three times in phosphate 
buffered saline (PBS): 137mM NaCl, 2.7mM KCl, 10mM Na2HPO4, 2mM NaH2PO4. 
Cells were then fixed in PBS with 4% formaldehyde for 30 minutes at room 
temperature. Coverslips for imaging were then washed again before being air dried, 
and mounted as described below. For immunofluorescence, cells were washed in PBS 
after fixation, then permeabilised in PBT (PBS, 0.1% Triton X-100, 0.3% BSA) for 30 
minutes. Cells were then incubated with the primary antibody overnight at 4°C. 
Antibodies were diluted in PBS with 0.3% BSA. These included mouse monoclonal 
antibodies to membrin, VAMP7 and GOSR1 (GOS28), obtained from Abcam, UK a 
mouse monoclonal antibody to Sec22L1 (Sec22b) from Abnova, Taiwan and a mouse 
monoclonal anti-Vti1a antibody from BD Biosciences, USA. A chicken anti-Ykt6 
antibody was obtained from J.C. Hay [36]. A rabbit anti-TI-VAMP (VAMP7) 
antibody was a gift from T. Galli (Institut Jacques Monod, Paris, France). Rabbit 
polyclonal antibodies against syntaxin 7 or 8 were obtained from Synaptic Systems, 
Germany. Anti-lysosomal associated protein 1 (anti-LAMP1) was a rabbit polyclonal 
obtained from Affinity Bioreagents (Colorado, USA). The primary antibody was 
removed, cells washed three times in PBT, and the secondary antibody added for one 
hour at room temperature. Secondary antibodies were diluted in PBS with BSA, at 
1:80 dilution for both anti-Mouse and anti-Rabbit IgG conjugated to TRITC (Sigma, 
USA) or 1:250 for Alexa-488 and Alexa-594-linked secondary antibodies obtained 
from Molecular Probes/Invitrogen, USA. Cells were washed again in PBT, and then 
dried, before mounting on ProLong Gold Antifade (Invitrogen, USA).   
Confocal microscopy 
Transfected cells were viewed using a Leica TCS-SP2-AOBS confocal microscope 
(Leica, Germany), using a 66.86µm pinhole, and a 63x water immersion objective 
with a 1.2 numerical aperture. For EYFP constructs, an excitation of 488nm was used, 
and an emission range of 500-540nm recorded. For TRITC-tagged secondary antibody 
signals, a 543nm laser was used for excitation, and emission at 570-680nm recorded. 
GFP was imaged using excitation at 488 nm and light collection at 500-550 nm. CFP 
was imaged using 405nm excitation and light collections between 500-550nm. HcRed 
was imaged by excitation at 494 nm and light collected at 610-700 nm. Alexa-488 was 
excited at 488nm, and emissions recorded from 500-550nm. Alexa-594 was excited at 
594nm, and emissions recorded from 605-670nm. 
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siRNA knockdown 
Expression of SNARE proteins was inhibited using siRNA oligonucleotide duplexes. 
Three duplexes were obtained against SYBL1, the gene for VAMP7 (Ambion, UK, 
siRNA ID# 241467, 241468, 241469) and three against Vti1a (Ambion, UK, siRNA 
ID# 37855, 37946, 38033). A Silence Negative Control siRNA#1 (Ambion, UK, 
AM4611) was also obtained. All siRNAs were resuspended in nuclease free water, to 
give a final concentration of 100nM when used for transfection. Cells were transfected 
with untagged Kv4.2, with or without KChIP1-EYFP and the siRNA or VSVG-GFP 
and siRNA. After 72h the cells were fixed and images were obtained of both KChIP-
EYFP and VSVG-GFP or Kv4.2 detected by immunofluorescent staining using an 
anti-Kv4.2 antibody (Exalpha Biologicals, Inc, USA) at 1:500 dilution with a TRITC-
tagged secondary antibody. Using the Leica LCD Lite software (Leica, Germany) 
regions of interest were drawn around the perimeter of the cell, and within the cell, to 
give a region of interest at the cell periphery including the plasma membrane that was 
1µm wide. The edge of the cell could easily be identified based on either background 
fluorescence or that due VSVG/KV4.2.  The total level of fluorescence was recorded 
for each region for both channels and the percentage of fluorescence at the plasma 
membrane was calculated. For Kv4.2 fluorescence, the background level of 
fluorescence at the cell periphery in the absence of co-expression of KChIP1 
(typically 10% of total [12]) was determined for each experiment and subtracted from 
values for cells expressing KChIP1. The resulting values were then divided by the 
mean from each experiment of the percentage of Kv4.2 at the plasma membrane in the 
presence of KChIP1. These data are shown as the normalised value for Kv4.2 traffic. 
Values for VSVG were similarly normalised to the control values. All data are 
expressed as Mean + SEM and statistical analyses (Student’s unpaired t-test) carried 
out.  
Real-time PCR 
After 72 hours post-transfection, mRNA was extracted from HeLa cellas using TRIzol 
reagent (Invitrogen, Paisley, UK) according to manufacturer’s instructions. mRNA 
was resuspended in 30µl RNase free water (Sigma, UK), and stored at -80°C. cDNA 
was produced using ImProm-II reverse transcriptase (Promega, USA) following 
manufacturer’s instructions, and using Oligo (dT)15 primers (Promega USA). The 
reaction proceeded with 5 minutes annealing at 25°C, 60 minutes at 42°C, and 15 
minutes of heat inactivation at 70°C. For real-time PCR, cDNA into a total volume of 
15µl, 7.5µl SYBR Green PCR master mix (Applied Biosystems, Warrington, UK) was 
used with 1µl primer mix (50mM each of forward and reverse primers). Each primer 
and cDNA combination was repeated in triplicate. Experiments were run on a BioRad 
iQ5 thermal cycler. After checking each run had completed correctly, the threshold 
cycle (Ct) was recorded, and averaged for each primer and cDNA set. The relative 
levels of mRNA for each primer and for each cDNA were calculated by comparison to 
results with primers for β-actin, using the 2-∆∆Ct method [37]. 
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Results 
KChIP1 EF-hand mutants distinguish between Kv4/KChIP1 and VSVG traffic 
to the plasma membrane 
When expressed alone in HeLa cells, Kv4.2 channels do not effectively reach the 
plasma membrane and remain trapped intracellularly [12]. The intracellular Kv4.2 was 
highly co-localised with two Golgi complex markers EYFP-Golgi (Figure 1A-C) or 
ARF1-EYFP (Figure 1D-F) indicating retention in the Golgi complex. In comparison, 
co-expression with KChIP1 results in traffic of Kv4.2 to the plasma membrane 
(Figure 1G) where it co-localises with KChIP1 [12]. Mutations of either a single EF 
hand (EF hand 3 in KChIP1EF3) or all three potentially functional EF hands (in 
KChIP1EF2-4) to disrupt coordination of divalent ions prevented the stimulatory 
effect on traffic of Kv4.2 (Figure 1H,I) and instead Kv4.2 was found on punctate 
intracellular structures that co-localised with the KChIPs (not shown) as seen 
previously for the triple mutant [12]. To compare this traffic pathway to the 
conventional pathway followed by VSVG we examined the effect of the inhibitory 
triple EF hand mutant on traffic of VSVG-GFP to the plasma membrane. Neither 
wild-type nor mutant KChIP1 had any effect on the levels of VSVG-GFP that reached 
the plasma membrane (Figure 1J-L). These conclusions were confirmed by 
quantification of the level of trafficking of proteins (Figure 1M,N) in assays in which 
fluorescence in peripheral regions of interest were determined [12] and normalised in 
comparison to control cells to provide a value for relative traffic to the plasma 
membrane for each experiment. The KChIP1 EF hand mutations appeared, therefore, 
to specifically impair the traffic of Kv4.2/KChIP1. 
Kv4.2/KChIP1 traffic requires Rab1 
Traffic of VSVG out of the ER requires the function of Rab1 [38]. It has been 
suggested, however, that some cargo traffic can be independent of Rab1 function [27, 
28]. We tested, therefore, whether traffic of Kv4.2/KChIP1 was Rab1-dependent. The 
approach used was to co-express the identified Rab1 GAP TBC1D20 [38]. Since this 
converts Rab1 into the inactive GDP-loaded form it acts as an effective and specific 
inhibitor of Rab1 function. As described previously [38] we found that co-expression 
of TBC1D20 inhibited traffic of VSVG-EGFP (data not shown) and also effectively 
inhibited traffic to the plasma membrane of Kv4.2 which remained intracellular but 
still co-localised with KChIP1 (Figure 2). These results indicate a common Rab1 
requirement for the conventional and the KChIP1-dependent trafficking pathways. 
KChIP1 vesicles co-localise with the SNARE proteins VAMP7 and Vti1a 
When KChIP1 is expressed alone in HeLa cells, it is present on punctate vesicular 
structures. However, the identity of these vesicles is unclear. The best overlap with 
other intracellular markers, albeit partial, was seen with the ER-Golgi intermediate 
compartment (ERGIC) marker, ERGIC-53, and the KChIP1 vesicles were suggested 
to be intermediates in ER to Golgi trafficking [11, 12]. To further characterise these 
vesicles, we aimed to determine which SNARE proteins were associated with them. 
HeLa cells expressing KChIP1-EYFP were stained with antibodies recognising 
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SNARES that are present in only one of the three complexes implicated in ER to 
Golgi traffic.  Membrin, a component of the SNARE complex in the conventional 
VSVG traffic pathway [31] did not show any significant co-localisation with the 
KChIP1-EYFP-labelled vesicles (Figure 3A). There was also no co-localisation of 
KChIP-EYFP with GOS28 (Figure 3B) a component of a SNARE complex in ERGIC 
to cis-Golgi traffic [32]. Similarly no co-localisation was seen with KChIP1 for 
Sec22b or Ykt6 (data not shown). In contrast, VAMP7 and Vti1a, two SNAREs 
implicated in traffic of prechylomicron transport vesicles from ER to Golgi [33], 
showed extensive co-localisation with KChIP1-vesicles (Figure 3C,D). Using a 
polyclonal antiserum against VAMP7 [39] similar results were found (data not 
shown). Furthermore, the EF hand mutants of KChIP1 which also labelled punctate 
vesicular structures were also co-localised with VAMP7 and Vti1a as shown for the 
triple EF hand mutant (Figure 3E,F).  
Since VAMP7 has also been shown to be part of a SNARE complex with syntaxins 7 
and 8 in late endocytotic traffic [40] we examined possible co-localisation of KChIP1 
vesicles with these proteins. Despite some overlapping localisation in the prenuclear 
region of the cells puncta labelled by KChIP were clearly distinct from those labelled 
by anti-syntaxin 7 (Figure 4A-C) or syntaxin 8 (Figure 4D-F). We also examined 
potential overlap with lysosomes. Over-expressed VAMP7 has been found associated 
with lysosomes [41] but we saw little overlap of staining for endogenous VAMP7 
with that for the lysosomal marker LAMP1. The results indicate that the VAMP7-
positive KChIP vesicles are not of late endosomal/lysosomal origin.  
Functional involvement of VAMP7 and Vti1a in traffic of Kv4.2/KChIP1 
The co-localisation data suggested a potential role for VAMP7 and Vti1a in the 
unconventional traffic route taken by Kv4.2/KChIP1. In order to test this possibility 
we used RNA silencing to examine the effect of knock-down of these SNARES on 
Kv4.2/KChIP1 traffic. Three distinct siRNAs were tested for both Vti1a and VAMP7 
and their effect on the localisation of KChIP1-EYFP and Kv4.2 was examined. Cells 
treated with the siRNAs were compared to cells in the absence of siRNA and also to 
cells in the presence of a silent siRNA. In control cells KChIP1 and Kv4.2 were co-
localised and found at the plasma membrane (Figure 5A). Treatment with a Vti1a or a 
VAMP7 siRNA blocked traffic of Kv4.2 channels to the plasma membrane and 
KChIP1-EYFP was also found to be intracellular (Figure 5A). The proportion of 
Kv4.2 present at the plasma membrane was determined and expressed as a normalised 
value for plasma membrane traffic. The silent siRNA had no effect on the amount of 
Kv4.2 traffic but all three Vtila and all three VAMP7 siRNAs had a significant 
inhibitory effect (Figure 5 B,C).  Further studies concentrated on use of the most 
inhibitory Vti1a or VAMP7 siRNA. 
 
In order to determine whether siRNA treatment affected the KChIP1 vesicles, staining 
for VAMP7 was carried out on cells transfected to express KChIP1-EYFP. As seen 
before VAMP7 co-localised with KChIP1 in control cells (Figure 6A). In cells treated 
with VAMP7 siRNA the levels of VAMP7 protein appeared to be significantly 
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reduced and the effectiveness of the siRNA knock down of VAMP7 was confirmed by 
real-time PCR to measure relative mRNA levels (Figure 6C). Despite the knock-
down, the KChIP1 vesicles did not show any obvious alterations in distribution or 
morphology and still showed co-localisation with the low levels of VAMP7 (Figure 
6B).  
To determine whether the ability of the Vti1a and VAMP7 siRNAs to inhibit Kv4.2 
traffic were specific we tested the effect of the selected siRNAs on VSVG traffic to 
the plasma membrane. The appearance of VSVG-GFP at the plasma membrane was 
apparent in control cells and also in cells treated with control siRNA or Vti1a and 
VAMP7 siRNAs (Figure 7A). Quantification of VSVG at the plasma membrane 
indicated that the siRNAs were without effect (Figure 7B). These finding support the 
conclusion that Vti1a and VAMP7 are specifically involved in an alternative traffic 
pathway that is distinct from the conventional pathway from the ER followed by 
VSVG. 
KChIP1 is the only one of the four KChIPs that is myristoylated and the only one that 
targets to the pool of intracellular vesicles [11, 13, 34]. KChIP2 in contrast is 
palmitoylated and targets to the plasma membrane when expressed alone [15, 34]. 
This raised the possibility that its stimulation of Kv4 traffic may involve interaction 
with the channel in a distinct cellular compartment and via a distinct cellular 
mechanism to that used by KChIP1. To test this possibility the effect of Vti1a and 
VAMP7 siRNAs on KChIP2 stimulated traffic of Kv4.2 was examined. No effect of 
the siRNAs was detected (Figure 7C,D) consistent with distinct pathways being used 
by KChIP1 and KChIP2 and again confirming the lack of a general disruptive effect 
of the siRNAs on cellular function. 
The studies so far were all carried out in HeLa cells in which KChIPs and Kv4 
channels are not normally expressed. To test the validity of the findings in a neuronal 
background, Neuro2A neuroblastoma cells were used. In this cell line, Kv4.2 
expressed alone again remained intracellular and co-localised with a Golgi complex 
marker (Figure 8A) and required co-expression of a KChIP for effective traffic to the 
plasma membrane as seen in HeLa cells. KChIP1 vesicles had a more perinuclear 
distribution than in Neuro2A cells compared to HeLa cells but showed co-localisation 
with both Vti1a and VAMP7 (Figure 8B,C). Treatment of Neuro2A cells with Vti1a 
and VAMP7 siRNAs specifically inhibited traffic of Kv4.2 channels to the plasma 
membrane and instead these remained, in part, in an intracellular compartment (Figure 
8E,F) suggesting that the Kv4.2/KChIP1 traffic also involves Vti1a and VAMP7 in 
neuronal cells. 
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Discussion 
The data presented here support a role for a VAMP7/Vti1a containing SNARE 
complex in a novel traffic pathway that is used by KChIP1 in its stimulation of Kv4 
traffic to the plasma membrane but not by the conventional pathway followed by 
VSVG protein. This pathway appears to exist in both non-neuronal (HeLa) and 
neuronal-derived (Neuro2A) cell lines. Where in the secretory pathway are the 
KChIP1 vesicles placed? KChIP1 is associated with 50-100 nm vesicles and we have 
previously concluded that the KChIP1 vesicles are an intermediate in ER to Golgi 
traffic based on their partial co-localisation with ERGIC-53 and the finding that an 
expressed N-terminal fragment of KChIP1 blocked Kv4.2 traffic and became fully co-
localised with an enlarged ERGIC compartment [11]. They were not COPII coated 
nor was COPII function crucial for Kv4.2/KChIP1 traffic although COPI function was 
[12]. This pathway is likely to be distinct from the other non-conventional ER to 
Golgi route, such as the well studied route for procollagen, as this is COPII-dependent 
and COPI-independent [25]. We now show that the VAMP-7-positive KChIP1 
vesicles do not overlap with endosomal or lysosomal markers consistent with the 
interpretation that they lie in the early exocytic pathway and with previous data 
suggesting a role for VAMP/Vti1a in ER to Golgi traffic of PCTVs [33].  
VAMP7 which is otherwise known as TI-VAMP [42] appears to be involved in 
multiple SNARE complexes in various traffic steps in different cell types. It has been 
shown to be involved in endosomal/lysosomal traffic where it can function in at least 
two distinct SNARE complexes [40, 41, 43].  Despite a focus on VAMP7 in 
endosomal traffic, VAMP7 is also involved in transport of apical vesicles to the 
plasma membrane in epithelial cells [39]. In addition, it is clear that many of the 
vesicular VAMP7 structures identified by immunofluorescence do not overlap with 
endosomal/lysosomal markers. In PC12 cells, VAMP7 overlaps to only a low extent 
with endosomal and lysosomal markers and it was noted that in HeLa cells the 
endogenous VAMP7  does not co-localise with the lysosomal protein LAMP1 [44]. 
We have now confirmed the latter observation in the present study. These findings 
suggest that VAMP7 may associate with a variety of other SNARE partners to 
function in multiple membrane traffic steps which may in part be cell type-specific 
[42]. It is noteworthy and potentially relevant to the current study that in neurons, 
VAMP7 is involved in axonal and dendritic outgrowth [45] and is associated with as 
yet unidentified vesicular structures present in axons and dendrites [44]. In PC12 cells 
the VAMP7-labelled vesicle seen by immuno-EM [44] are very similar in size and 
morphology to those labelled by KChIP1 in HeLa cells [12].  
The specificity of siRNA on Kv4.2/KChIP1 traffic and lack of general disruption of 
the secretory pathway was demonstrated by the lack of effect on VSVG traffic to the 
plasma membrane. In addition, Vti1a and VAMP7 siRNAs had no effect on Kv4.2 
traffic stimulated by KChIP2. This latter result is not surprising given the differing 
intrinsic localisation of KChIP2 compared to KChIP1. Since KChIP2 effectively 
targets to the plasma membrane due to its palmitoylation even in the absence of Kv4.2 
[15, 34] it would be unlikely to encounter Kv4.2 in the same compartment as KChIP1 
but may do so at the level of the Golgi where Kv4.2 accumulates when expressed 
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alone and where many palmitoyl transferases are located [46]. Interestingly,  KChIP2 
is expressed at highest levels in the heart [47] where it is the major KChIP and is 
indispensable for normal Kv4 function [48] and VAMP7 is apparently not expressed 
in the heart [49]. 
SNARE complexes suggested to mediate ER to Golgi traffic all contain syntaxin 5 
and rBet1 but three distinct complexes have been indentified based on the identity of 
the other two SNARES. KChIP1/Kv4.2 traffic appears to involve Vti1a and VAMP7 
based on co-localisation and functional siRNA data. Vti1a has been shown to interact 
with syntaxin 5 [50] and both Vti1a and VAMP7 have been found to be quantitatively 
recovered in a SNARE complex with syntaxin 5 and rbet1 that was implicated in ER 
to Golgi traffic of PCTVs [33]. Since these organelles are expressed in a tissue 
specific manner it was possible that Vti1a/VAMP7-dependent ER to Golgi traffic 
could have been enterocyte specific process. Our data further highlights the distinctive 
nature of Kv4.2/KChIP1 traffic and now suggest that Vti1a/VAMP7 define a non-
conventional pathway that may be used for the traffic of a range of cargo proteins in 
neuronal and non neuronal cell types. 
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Figure Legends 
 
Figure 1. Effects of KChIP1 and KChIP1 with EF-hand mutations on traffic of Kv4.2 
and VSVG to the plasma membrane.  Hela cells were transfected to co-express Kv4.2 
and EYFP-Golgi (A-C) or ARF1-EYFP (D-F) or with wild-type KChIP1-EYFP (G), 
with the single EF hand mutant KChIP1EF3-EYFP (H) or with the triple EF-hand 
mutant KCHIP1EF2-4-EYFP (I) and Kv4.2 localisation determined by using anti-
Kv4.2 immunostaining. Hela cells were transfected to express VSVG-GFP alone (J), 
or with wild-type KChIP1 (K) or the triple EF-hand mutant KCHIP1EF2-4-HcRed (L) 
and VSVG-GFP localisation determined by confocal imaging. The scale bars 
represent 10 µm. Normalised traffic of Kv4.2 (M) or VSVG-GFP (N) in the presence 
of various KChIPs was quantified and the data shown as Mean + SEM from 20 cells 
for each condition. 
 
Figure 2. Inhibition of Rab1 function prevents traffic of Kv4.2/KChIP1 to the plasma 
membrane. HeLa cells were co-transfected to express both KChIP1-EYFP and Kv4.2 
and immunostained with anti-Kv4.2 so that localisation of KChIP1 (A) and Kv4.2 (B) 
could be visualised. Alternatively the cells were additionally co-transfected to express 
the Rab1 GAP TBC1D20 (D-F). The colour overlays (C,F) show co-expressed 
proteins in green (KChIP1-EYFP) and red (Kv4.2) with co-localisation appearing in 
yellow.  The scale bars represent 10 µm. Normalised traffic of Kv4.2 in the presence 
or absence of TBC1D20 was quantified and the data shown as Mean + SEM from 20 
cells for each condition. 
 
Figure 3. Co-localisation of KChIP1 with VAMP7 and Vti1a. HeLa cells were 
transfected to express KChIP1-EYFP or KChIP1EF2-4-EYFP as indicated, fixed and 
immunostained with mouse monoclonal antibodies specific for membrin (A), GOS28 
(B), VAMP7 (C,E) or Vti1a(D,F). The images show the localisation of the KChIP1 
and the indicated SNARE proteins and the colour overlays show KChIP1-EYFP in 
green and anti-SNARE staining in red with co-localisation appearing in yellow.  The 
scale bars represent 10 µm in the main figures and 2 µm in the enlarged inserts.  
 
Figure 4. Lack of co-localisation of KChIP1 with syntaxin 7 and 8 or VAMP7 with 
LAMP1. HeLa cells were transfected to express KChIP1-EYFP, fixed and 
immunostained with mouse monoclonal antibodies specific for syntaxin 7 (A-C) or 
syntaxin 8 (D-F). The images show that KChIP1 punctae are distinct from those 
stained by anti-syntaxin 7 or 8. In cells immunostained with anti-VAMP 7 adn anti-
LAMP1 (G-I) there was little overlap of the stained punctae. The colour overlays 
show KChIP1-EYFP or anti-VAMP7 in green and anti-syntaxin 7 and 8 and anti-
LAMP1 in red with co-localisation appearing in yellow.  The scale bars represent 10 
µm in the main figures and 2 µm in the enlarged inserts.  
17 
 
 
Figure 5. VAMP7 and Vti1a siRNA specifically inhibits traffic of Kv4.2/KChIP1 to 
the plasma membrane in HeLa cells. A, Hela cells were co-transfected to express both 
KChIP1-EYFP and Kv4.2 and immunostained with anti-Kv4.2 so that localisation of 
KChIP1 and Kv4.2 could be visualised. Control cells are shown as well as cells co-
transfected with VAMP7 or Vtila siRNA as indicated. The colour overlays show co-
expressed proteins in green (KChIP1-EYFP) and red (Kv4.2) with co-localisation 
appearing in yellow.  The scale bars represent 10 µm. Normalised traffic of Kv4.2 in 
control cells and cells co-transfected with Vti1a (B) or VAMP7 (C) siRNAs was 
quantified and the data shown as Mean + SEM from 20 (Vti1A) or 25 (VAMP7) cells 
for each condition. 
 
Figure 6. VAMP7 knock-down does not affect the morphology or distribution of 
KChIP1 vesicles. HeLa cells were transfected to express KChIP1-EYFP, fixed and 
immunostained with anti-VAMP7 in the absence (A) or presence (B) of VAMP7 
siRNA so that localisation of KChIP1 and VAMP7 could be visualised. The colour 
overlays show co-expressed proteins in green (KChIP1-EYFP) and red (VAMP7) 
with co-localisation appearing in yellow.  The scale bars represent 10 µm. C. For 
quantitative PCR, mRNA was prepared from HeLa cells transfected in the presence of 
silent or VAMP7 siRNA and relative mRNA levels determined using real-time PCR. 
 
Figure 7. VAMP7 and Vti1a siRNA do not inhibit traffic of VSVG or Kv4.2/KChIP2 
to the plasma membrane. HeLa cells were transfected to express VSVG-GFP and 
imaged. Control cells are shown as well as cells co-transfected with silent, VAMP7 or 
Vtila siRNA as indicated (A). Normalised traffic of VSVG in control cells and cells 
co-transfected with silent, Vti1a or VAMP7 siRNAs was quantified and the data are 
shown from 20 cells for each condition (B). HeLa cells were transfected to express 
KChIP2 and Kv4.2 and immunostained with anti-Kv4.2 to allow imaging of Kv4.2 
localisation. Control cells are shown as well as cells co-transfected with silent, 
VAMP7 or Vtila siRNA as indicated (C). Normalised traffic of Kv4.2 in control cells 
and cells co-transfected with silent, Vti1a or VAMP7 siRNAs was quantified and the 
data shown as Mean + SEM from 30 cells for each condition (D). The scale bars 
represent 10 µm. 
 
Figure 8. VAMP7 and Vti1a siRNA specifically inhibits traffic of Kv4.2/KChIP1 to 
the plasma membrane in Neuro2A cells. A,  Neuro2A cells were transfected to co-
express Kv4.2 and EYFP-Golgi.  B,C, Neuro2a cells were transfected to express 
KChIP1-EYFP, fixed and immunostained with anti-Vti1a or anti-VAMP7 as 
indicated. D, Neuro2a cells were co-transfected to express both KChIP1-EYFP and 
Kv4.2 and immunostained with anti-Kv4.2 so that localisation of KChIP1 and Kv4.2 
could be visualised. Control cells are shown as well as cells co-transfected with silent, 
VAMP7 or Vtila siRNA as indicated. E, Normalised traffic of Kv4.2 in control cells 
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and cells co-transfected with siRNAs was quantified and the data shown as Mean + 
SEM from 20 cells for each condition. The scale bars represent 10 µm. 
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